Antifom

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antifom

Quick Facts

Property Description
Active Ingredient Dimethicone (Polydimethylsiloxane)
Form Liquid (oral) and Topical Preparation (cream/ointment)
Pharmacological Class Antifoaming Agent / Skin Protectant
Origin Synthetic (Silicone-based polymer)
Absorption Non-systemically absorbed (Chemically inert)

What Type of Medicine is Antifom? (Identity and Classification)

Antifom is a pharmaceutical preparation primarily classified as an Antifoaming Agent for internal use and a Skin Protectant for external application. The medication's core active component, Dimethicone, places it within a distinct pharmacological group defined by its physical mode of action rather than its chemical properties. The product is commonly available as an Over-the-counter (OTC) product and is formulated as both a Liquid (oral suspension) for the Oral route and a Topical Preparation for external use. This dual functionality establishes its utility for managing both internal gas and external skin protection needs, with the specific brand positioning of Antifom often emphasizing its liquid oral form for use in infants and children.

Dimethicone: Composition and Origin

The active ingredient in Antifom is Dimethicone, a synthetic, high-molecular-weight compound formally designated as Polydimethylsiloxane (PDMS). This substance is a type of silicone-based polymer that is highly stable and considered chemically inert. The Composition ensures that the ingredient remains non-systemically absorbed, meaning it passes through the body or stays on the skin's surface before being eliminated unchanged. The compound's stability and lack of systemic absorption differentiate it from drugs that rely on metabolic pathways.

What is the General Purpose of Antifom's Action? (High-Level Benefit)

The general purpose of Antifom is to provide physical relief by altering the dynamics of air and liquid interfaces, classifying it functionally as a Carminative. This action is intended to manage the physical discomfort associated with excess gas and bloating when taken orally, as the polymer reduces surface tension. A typical use scenario involves administering the liquid oral form to ease the distress caused by swallowed air or dietary fermentation. When applied topically, the same polymer quality allows the compound to form an occlusive, hydrophobic layer on the skin, which functions as an effective skin protectant to minimize water loss and friction.

Regulatory References

  1. MedlinePlus

What side effects are possible with Antifom?

Possible Side Effects and Safety Information

The safety profile of Antifom (a defoaming agent, often simethicone-based) is generally considered favorable, primarily due to its lack of systemic absorption into the bloodstream.

Adverse Reactions and Safety Restrictions

Adverse reactions documented in regulatory sources are rare or very rare. These are mainly limited to Immune system disorders and Skin and subcutaneous tissue disorders, reflecting potential hypersensitivity to the product or its excipients. Serious adverse reactions are exceptionally rare but may include severe allergic reactions such as Anaphylaxis and severe cutaneous events like Stevens Johnson syndrome or Toxic Epidermal Necrolysis (TEN).

System-Organ Class Frequency Classification Key Adverse Reactions
Immune system disorders Rare/Very rare Hypersensitivity, Anaphylaxis
Skin/Subcutaneous tissue Very rare Rash, Pruritus, Stevens Johnson syndrome, TEN

Population-Specific Safety Considerations

Pregnancy and Breast-feeding: Due to the product's non-absorbable nature, it is not expected to pose a risk to the fetus or be transferred into breast milk. Use during pregnancy and breast-feeding is generally regarded as safe based on current epidemiological data and regulatory assessment.

Dose-Related Safety and Limitations

Caution is advised against exceeding the maximum stated dose. Though Antifom itself has low toxicity, any combination product or product adulteration may carry additional risks, such as hepatic damage, especially if a product component includes paracetamol, a risk that is greater in patients with existing liver disease. Safety monitoring is concentrated on preventing drug interactions, particularly if Antifom is used concurrently with carbamazepine, which may increase the risk of carbamazepine toxicity. Use requires caution in patients with severe renal or severe hepatic impairment.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Antifom (Dimethicone/Simethicone) is defined by its chemically inert properties and negligible systemic absorption. This leads to a low risk of systemic toxicity, as documented in government regulatory sources, including FDA and EMA prescribing information. No systemic toxic effects, such as cardiovascular or central nervous system complications, are officially reported.


Overdose Manifestations and Management

Domain Official Regulatory Statement
Documented Manifestations Specific systemic symptoms are generally not reported. The only commonly documented theoretical manifestation is constipation
Severe Outcomes Systemic toxic effects are considered unlikely; no life-threatening outcomes are officially documented
Antidote No specific antidote is known for Dimethicone overdose
Supportive Measures Management is restricted to symptomatic and supportive treatment, including observation and the use of fluids to address potential constipation

When to Seek Urgent Medical Help

Regulatory authorities mandate that individuals must seek emergency medical attention or call a Poison Control Center right away following any known or suspected overdose or accidental ingestion of Antifom. This is a mandatory, non-negotiable step required regardless of the low systemic toxicity profile. No specific population-related increase in overdose severity is officially documented.

Therapeutic Uses of Antifom

The primary therapeutic purpose of Antifom (dimethicone) is to help manage symptoms related to excessive gas and physical discomfort in the gastrointestinal tract.

It is commonly used to provide supportive symptomatic relief from acute manifestations of trapped gas, functional bloating, and the distress of infant colic.


Targeting Gas Discomfort and Bloating

Antifom is applied in settings marked by temporary physiological imbalance, specifically helping to address the uncomfortable physical symptoms that create noticeable interference with daily comfort, such as pressure, fullness, and abdominal distension. It contributes to improved day-to-day comfort by easing the overall symptom burden. It is relevant when supportive symptom management is appropriate for symptoms associated with acute or episodic changes.

Uses in Specific Scenarios

This medication is relevant when symptoms become temporarily overwhelming, often occurring after consuming gas-producing foods or during periods of digestive fluctuation. In infants, it is applied in addressing the intense, disruptive gas-related symptoms common in colic, assisting with maintaining functional stability and supporting general well-being during symptomatic phases.


Quick Fact: Relief for Trapped Gas Antifom is applied in addressing symptom clusters that may become intense or disruptive, specifically focusing on gas-related discomfort.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Antifom?

The official eligibility profile for Antifom (Dimethicone/Simethicone) is exceptionally broad, reflecting its classification as a medicine that is non-systemically absorbed by the body. Regulatory authorities define patient eligibility based on a few primary restrictions, with use permitted across most general populations.


Absolute Contraindications

Use of Antifom is strictly contraindicated for individuals who present with the following specific conditions, as documented in regulatory labeling:

Condition Eligibility Status
Known Allergy/Hypersensitivity Prohibited from use due to the risk of severe reaction to the active ingredient or excipients.
Gastrointestinal Obstruction or Perforation Prohibited from use due to potential safety risks in mechanically blocked or compromised digestive tracts.

Permitted Populations

The lack of systemic absorption defines eligibility for populations often restricted for other medicines:

  • Age-Based Use: The medicine is permitted for use across the entire age spectrum, including newborns and infants, as well as adults and older adults.
  • Pregnancy and Lactation: Use is permitted during both pregnancy and breastfeeding.
  • Organ Function: No specific restrictions are required for patients with hepatic impairment (liver function) or renal impairment (kidney function), as these organs are not involved in the drug's metabolism or clearance.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Antifom (Dimethicone/Simethicone) is defined by its core pharmacology as a non-systemically absorbed, inert polymer. Regulatory documents confirm that the product does not enter the bloodstream and therefore does not interact with major systemic drug metabolism pathways, specifically CYP enzymes or drug transporters. For this reason, official labeling for Antifom does not list any formal combinations as contraindicated due to systemic interaction risk.


Physical Binding and Administration Timing

The entirety of the documented interaction profile is restricted to a physical binding mechanism within the gastrointestinal tract. This non-systemic effect is officially noted for co-administration with Oral Thyroid Hormones (such as Levothyroxine). Antifom has the potential to physically bind to the hormone, which can result in its reduced absorption and decreased bioavailability.

This interaction leads to a mandatory regulatory requirement for administration timing separation. Official Prescribing Information requires that Antifom and all oral thyroid replacement medications must be administered at least four hours apart to mitigate the documented physical binding effect and prevent reduced efficacy. The potential for reduced thyroid hormone absorption is specifically noted as a concern for vulnerable populations, including infants and patients with gastrointestinal/malabsorption disorders.

Mechanism of Action

Physicodynamic Breakdown of Trapped Intestinal Gas

The primary mechanism of Dimethicone is purely physicodynamic, acting locally within the gastrointestinal tract to modify the air-liquid interface of accumulated gas. By dramatically reducing the surface tension of the viscous foam stabilized by mucus, the drug causes small, trapped bubbles to coalesce into large pockets of free gas. This mechanical action results in the physical liberation and subsequent transit of intestinal gas through the natural pathway.


Non-Systemic Stabilization of the Skin Barrier

In its topical application, Dimethicone acts as a chemically inert agent that forms a hydrophobic, occlusive film on the stratum corneum. This physical barrier is designed to reduce the rate of transepidermal water loss (TEWL), supporting the physiological outcome of reduced TEWL and the preservation of skin barrier structure. As the compound is not absorbed, this mechanism is entirely localized, creating a physical boundary that mediates contact with friction and external factors.

Dosage and Administration Information

How to Use Antifom

Antifom (dimethicone) is administered by the oral route and should be used exactly as directed on the product label or by a healthcare professional. To optimize the drug's effect, each dose is typically taken after meals and at bedtime.

Official Administration Protocol

Administration Element Official Instruction
Timing and Frequency Take up to four times a day: after each meal and at bedtime.
Maximum Dose The self-medication dose for adults and teenagers must not exceed 500 mg in a 24-hour period.
Chewable Tablets Chew the tablet thoroughly before swallowing; do not swallow it whole.
Liquid/Suspension Shake the liquid container well before measuring. Use the provided dosing syringe, dropper, or measuring device to ensure accurate measurement. Liquid drops may be mixed with a small amount of water or infant formula.

Missed Dose Instructions

If Antifom is taken on a regular schedule and a dose is missed, take it as soon as it is remembered. However, if it is nearly time for the next scheduled dose, skip the missed dose and continue with the regular schedule. Do not take a double dose to compensate for a missed one. Pediatric dosing must be determined by a healthcare provider.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Antifom

Research Evidence for Oral Use: Gas, Bloating, and Fullness

Research on the antifoaming ingredient was evaluated in multiple short-term, placebo-controlled Randomized Controlled Trials (RCTs). These studies explored how outcomes related to physical discomfort changed over defined time intervals in adult populations experiencing functional abdominal symptoms. Studies reported measurements related to daily, functional gas symptoms have shown some variability over observation periods generally lasting less than two weeks. Long-term effects are not fully established for managing recurring gas and bloating, and the observation periods were limited in many trials. Separately, the ingredient was studied for use as an adjunct during diagnostic procedures (e.g., colonoscopy). In this setting, studies monitored technical outcomes, and data show patterns related to reduced foam accumulation, and studies describe an association with improved visualization for clinicians examining the area.


Research Evidence for Oral Use: Infant Colic and Excessive Crying

Research on the liquid oral form was studied for outcomes related to excessive crying and fussiness in infants diagnosed with colic. This evidence is generally derived from placebo-controlled RCTs, with multiple systematic reviews aggregating the trial data. Researchers examined outcomes related to changes in the total daily duration of crying. However, when comparing the findings across the various trials, the evidence is limited in suggesting consistent patterns. Meta-analyses have reported that the measured outcomes related to daily crying duration were often not significantly different from those observed in the placebo groups. The findings were mixed, and the research base is noted for having significant differences in study design and inconsistent results.


Research Evidence for Topical Use: Skin Protection and Barrier Function

Research evaluated the ingredient's function as a skin protectant. Studies explored how the ingredient affects the skin's physical properties in adults with healthy and sensitive skin. Outcomes monitored included Transepidermal Water Loss (TEWL)—a measure of the skin's moisture barrier—and general hydration levels. Studies explored the ingredient's function in forming an occlusive barrier. Research highlights measured changes showing patterns related to reduced moisture loss. The influence of the specific cream or lotion vehicle used in the topical studies is a notable limitation documented in the research.

Key Studies & References

  1. Comparison of common interventions for the treatment of infantile colic: a systematic review of reviews and guidelines

Frequently Asked Questions (FAQ)

Common questions about Antifom (FAQ)

Q: How quickly is Antifom expected to start working?

A: Official product information suggests that due to the drug’s physical and localized action in the digestive tract, the onset of effect may begin within minutes. Relief from gas and bloating discomfort is generally reported to occur within an hour or two. The official administration protocol for chewable tablets describes the recommendation to chew them thoroughly before swallowing to facilitate action.

Q: How long does the effect of Antifom typically last?

A: The duration of the effect is reflected by the recommended administration schedule. Official instructions guide patients to take the medication up to four times a day, typically after meals and again at bedtime, which dictates the necessary re-dosing interval for continued relief from symptoms.

Q: Does Antifom have known interactions with common over-the-counter pain relievers?

A: Regulatory information indicates that the interaction profile of this medicine is restricted to physical binding effects within the gut. The specific warning is the separation requirement for oral thyroid hormones. Specific regulatory review of common over-the-counter pain relievers, such as ibuprofen, has not indicated systemic interaction risks.

Q: Does Antifom interact with oral contraceptives?

A: Regulatory documents confirm that Antifom is not absorbed into the bloodstream and does not rely on systemic drug metabolism pathways for its action. For this reason, official labeling does not list an interaction with oral contraceptives or similar systemic medications.

Q: What should a patient do if they accidentally take more Antifom than intended?

A: The official product label includes an 'Overdose warning' which states that immediate medical help or contact with a Poison Control Center is advised if an excessive amount is accidentally consumed, even in the absence of symptoms.

Q: Are there any specific warnings about driving or operating machinery while on Antifom?

A: Official product labeling does not typically list central nervous system side effects, such as drowsiness or dizziness. These are the usual basis for specific warnings against driving or operating machinery. The lack of systemic absorption is consistent with this safety profile.

Q: Does Antifom need to be gradually stopped, or can it be discontinued suddenly?

A: Given the drug's non-systemic, purely physical mechanism of action—meaning it does not enter the bloodstream—official documentation is consistent with discontinuation at any time. Tapering instructions are not required in the labeling.

Q: Are changes in mood or sleep listed as a potential effect of Antifom?

A: The official safety profile for Antifom is very limited due to its non-systemic action. Regulatory sources list adverse reactions primarily related to allergic or skin disorders, and they do not include changes in mood, behavior, or sleep disturbances.

Q: What is the difference between the generic and brand name versions of Antifom?

A: Regulatory guidance dictates that generic versions must contain the identical active ingredient in the same strength and dosage form as the brand name product. However, generics may differ in their inactive ingredients, such as flavorings or other excipients.

Q: What are the guidelines for using alcohol while taking Antifom?

A: Due to the non-systemic nature of the active ingredient, official product labeling for the simethicone-only product does not typically list warnings or restrictions regarding alcohol consumption.

Q: Can Antifom interact with herbal supplements?

A: Official documents focus on known drug-drug interactions, and herbal supplements are not systematically reviewed. However, because the drug is non-systemically absorbed, systemic interactions with herbal supplements are not expected.

Q: Does Antifom cause weight gain or weight loss?

A: Official safety information does not list changes in body weight, whether gain or loss, as a documented adverse reaction.

Q: Is it normal to feel a mild headache after starting Antifom?

A: The official safety profile documents a very limited range of adverse reactions, primarily allergic/skin-related issues. Headache is not listed in the product’s official safety profile.

Q: Are there different versions or strengths of Antifom available?

A: Official product monographs confirm that the active ingredient is available in multiple strengths and dosage forms. These include various oral suspensions (drops), chewable tablets, and softgels, depending on the manufacturer and specific product.

Q: Is Antifom intended for long-term or short-term use?

A: The regulatory context of use is defined for the short-term, temporary relief of gas symptoms. Research studies examining the drug for common functional gas symptoms typically feature observation periods lasting only a few weeks.

Q: Do all side effects of Antifom require calling a doctor?

A: Official documents highlight that rare, serious adverse reactions, such as severe allergic reactions (e.g., anaphylaxis) or severe skin disorders, are listed as conditions that warrant immediate medical evaluation. Other documented potential reactions are generally rare and non-severe.

Q: Is Antifom addictive or habit-forming?

A: The product is classified as an over-the-counter medicine, and its non-systemic, chemically inert action means it has no central nervous system effects. Therefore, it has no abuse or dependence liability.

Q: Is Antifom available without a prescription in some places?

A: The product's active ingredient is classified by the FDA as an Over-The-Counter (OTC) medicine, making it available for self-medication without requiring a prescription.

Q: Are there any required tests or monitoring needed while using Antifom?

A: Due to its non-systemic absorption and favorable safety profile, regulatory documents do not specify required laboratory tests or specific medical monitoring protocols during use.

Q: Is it necessary to take Antifom at a specific time of day?

A: The official administration instructions define timing relative to events, such as taking the dose after meals and at bedtime. There is no requirement to take the medicine at a specific absolute time of day.

Q: Can Antifom affect the results of certain medical lab tests?

A: Due to the drug’s non-systemic absorption, it is not expected to interfere with routine blood or urine laboratory tests. However, the ingredient has been studied and used as a physical aid during some diagnostic imaging procedures to improve visibility.

Q: What is the average reported duration of treatment with Antifom?

A: The reported duration of treatment for self-care is generally aligned with short-term symptomatic relief. Official guidance advises seeking professional help if symptoms persist or worsen beyond typical self-treatment intervals of a few weeks.

Q: Does Antifom contain lactose or gluten?

A: The presence of inactive ingredients, or excipients, such as lactose or gluten, is dependent on the specific manufacturer and product formulation. This information is available in the 'Inactive Ingredients' section of the official product labeling for the formulation being used.

Q: Has the drug Antifom been recalled in the past?

A: FDA enforcement records show that the active ingredient itself has generally not been the subject of a recall. However, some specific combination products that contained the ingredient have been recalled for issues related to the other components or manufacturing processes.

Q: What are the signs that Antifom may not be working as expected?

A: Official patient instructions indicate that professional advice should be sought if symptoms of gas or bloating do not improve, if they worsen, or if new, concerning symptoms appear. These concerning signs can include vomiting, severe abdominal pain, or bloody stool.

Q: Are there warnings about sun exposure while using Antifom?

A: Warnings regarding sun exposure or photosensitivity reactions are not listed in the official safety and warnings sections of the product labeling. This is consistent with the drug’s non-systemic absorption.

How should Antifom be stored and disposed of?

How to Store and Dispose of Antifom

The storage and disposal of Antifom (Dimethicone) must adhere to official regulatory guidance to maintain product stability and safety.

Storage Requirements

Antifom must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). It is essential to keep the product from freezing and exposure to excessive heat or moisture. The medicine must be kept in its original container with the cap tightly closed and stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Antifom should be disposed of via a drug take-back program. If one is unavailable, the medicine must be mixed with an unappealing substance (like dirt or coffee grounds), sealed in a bag, and placed in the household trash. The product must not be flushed down the toilet or sink (wastewater disposal) unless specifically instructed by regulatory authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antifom found in:

A-Z Index: